Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Current Medicinal Chemistry|February 16, 2013
Rationally designed multi-targeted agents against neurodegenerative diseasesW J Geldenhuys, C J Van der SchyfLife Sciences|January 1, 1988
The conformation of (-) 8 alpha and (-) 8 beta-hydroxy-delta 9-tetrahydrocannabinols and their interactions with model membranesC J Van der Schyf, T Mavromoustakos, A MakriyannisPharmacological Research Communications|May 1, 1986
Characterization of NGP 1-01, an aromatic polycyclic amine, as a calcium antagonistC J Van der Schyf, G J Squier, W A CoetzeeChemical Research in Toxicology|May 17, 2000
Studies on the in vivo biotransformation of the tobacco alkaloid beta-nicotyrineX Liu, K Castagnoli, C J Van Der Schyf, et al.Die Pharmazie|January 1, 1996
The biological activity of two symmetric amine derivatives of the cis-syn-cis triquinane systemW Liebenberg, P H Van Rooyen, C J Van Der SchyfDie Pharmazie|December 29, 2000
Effects of derivatives of NGP 1-01, a putative calcium channel antagonist, on electrically stimulated guinea-pig papillary muscleW Liebenberg, J J Van der Walt, C J Van der SchyfNeurotoxicity Research|July 2, 2003
Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatumC J van der Schyf, K Castagnoli, S Palmer, et al.Archiv Der Pharmazie|February 17, 2000
Structure-activity relationships of polycyclic aromatic amines with calcium channel blocking activityS F Malan, J J Van der Walt, C J Van der SchyfLife Sciences|February 7, 2001
Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesiaD W Eyles, S M Pond, C J Van der Schyf, et al.Journal of Neurochemistry|June 15, 2005
Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitineP R Lockman, C J Van der Schyf, T J Abbruscato, et al.Pageof 4